IHWM
TOVX icon

Iron Horse Wealth Management’s Theriva Biologics TOVX Stock Holding History

Iron Horse Wealth Management’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14
Closed -$25 – 641
2024
Q4 		$25 Hold
14
– – ﹤0.01% 503
2024
Q3 		$19 Sell
14
-1
-7% -$5 ﹤0.01% 504
2024
Q2 		$86 Hold
15
– – ﹤0.01% 473
2024
Q1 		$171 Buy
+15
New +$176 ﹤0.01% 450

Other funds holding TOVX

IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return